OLIF25™ /OLIF51™ Study

Stopped early

Conditions studied: Degenerative Disc Disease, Scoliosis

In brief

The purpose of this single-arm observational study is to observe and document clinical outcomes of the OLIF25™ and OLIF51™ procedures in patients diagnosed with degenerative disc disease or degenerative scoliosis, and report the rate of adverse events of interest through the 24 months follow-up visit.

Key facts

Study ID: NCT02657421
Run by: Medtronic Spinal and Biologics
People needed: 168
Starts: 2015-11-01
Expected to finish: 2018-05-03
Last updated by the study team: 2018-06-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Patient is 18 years of age or older.
Patient agrees to participate in the study and is able to sign the informed consent/data release form.
Patient is undergoing surgery from L2-L5 for OLIF25™ and/or from L5-S1 for OLIF51™ for degenerative disc disease or degenerative scoliosis.

You may not qualify if…

Illiterate or vulnerable patients (e.g. minors, participants incapable of judgment).

Where it is running

Advanced Neurosurgery Associates — Murrieta, California, United States
University of California San Francisco (UCSF) — San Francisco, California, United States
The B.A.C.K. Center — Melbourne, Florida, United States
Foundation for Orthopaedic Research and Education (FORE) — Tampa, Florida, United States
NewYork-Presbyterian/The Allen Hospital — New York, New York, United States
Alleghany Health Network Research Institute — Pittsburgh, Pennsylvania, United States
Ste Elisabeth hospital — Brussels, Belgium
FN Ostrava — Ostrava, Poruba, Czechia
Clinique Du Mail — La Rochelle, France
Azienda Ospedaliera - Ospedale Civile di Legnano — Legnano, Italy
CUF Descobertas — Lisbon, Portugal
Orthospine Group — San Juan, Puerto Rico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.